Hearing Loss Clinical Trial
Official title:
Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA-study)
Gentamicin, in combination with a beta-lactam antibiotic, is commonly used for treatment of
neonatal sepsis. Neonates have a high volume of distribution. It is a paradox that most
neonatal dosing schedules still recommend lower gentamicin doses (4-5 mg/kg) than in older
children (≥ 7 mg/kg). In the neonatal unit in Tromsø a simplified gentamicin high-dose (6
mg/kg) regimen has been in use since 2004.
The investigators have previously shown that this regimen was associated with low number of
elevated trough levels, low numbers of prescription errors and no evidence for ototoxicity in
the immediate neonatal period. However, the long-term safety of gentamicin therapy in
neonates is not well studied when it comes to ototoxicity and possible nephrotoxicity.
The objective of the current study is therefore to perform a detailed hearing evaluation,
including an extended high-frequency (EHF; 9-16 kHz) audiometry, in a follow-up study of
children (participants) aged 6-15 years who were exposed to a high-dose gentamicin regimen in
the neonatal period. Moreover, we will investigate blood pressure and urine biomarkers to
assess renal tubular function. The aim is to include 250 children exposed to gentamicin in
the neonatal period and a control group of 25 healthy children.
EHF audiometry is a more sensitive method for detecting ototoxic damage and provides evidence
of ototoxicity before any hearing loss is detected by conventional systems. This is the
background for choice of method.
The primary outcome is the difference in average hearing threshold in the EHF range between
the control group and the exposed group.
Secondary outcomes are i) difference in average hearing threshold in the EHF range between
the children with gentamicin trough levels > 1.0 mg/L versus those who had lower trough
levels, ii) markers of renal tubular function (kidney injury molecule 1) and iii) blood
pressure.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04696835 -
fNIRS in Pediatric Hearing Aids
|
N/A | |
| Completed |
NCT03662256 -
Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine
|
N/A | |
| Completed |
NCT04602780 -
Evaluating the Revised WORQ in CI Users
|
||
| Completed |
NCT03723161 -
Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
|
||
| Completed |
NCT05086809 -
Investigation of an Updated Bone-anchored Sound Processor
|
N/A | |
| Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
| Completed |
NCT03428841 -
Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients
|
N/A | |
| Completed |
NCT04559282 -
Home Test of New Sound Processor
|
N/A | |
| Enrolling by invitation |
NCT03345654 -
Individually-guided Hearing Aid Fitting
|
||
| Completed |
NCT06016335 -
MRI-based Synthetic CT Images of the Head and Neck
|
N/A | |
| Completed |
NCT05165121 -
Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids
|
N/A | |
| Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
| Terminated |
NCT02294812 -
Effects of Cognitive Training on Speech Perception
|
N/A | |
| Completed |
NCT04622059 -
AUditive Direct In-utero Observation (AUDIO): Prenatal Testing of Congenital Hypoacusis
|
N/A | |
| Recruiting |
NCT02558478 -
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing
|
N/A | |
| Withdrawn |
NCT02740322 -
Validating the Hum Test
|
N/A | |
| Completed |
NCT01963104 -
Community-Based Kiosks for Hearing Screening and Education
|
N/A | |
| Completed |
NCT01892007 -
Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users
|
N/A | |
| Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
| Withdrawn |
NCT01223638 -
The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism
|
N/A |